Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“We have previously demonstrated that CFR to adenosine was significantly increased after systemic infusion of L-NMMA in normal volunteers but not in recently transplanted denervated hearts.”
American journal of physiology. Heart and circulatory physiology • 2007 | View Paper
“In a separate series of experiments, MBF during adenosine was reduced in the presence of l-NMMA (p < 0.05 analysis of variance).”
“This was most apparent at the low dose of adenosine, where MBF response to adenosine was blunted in the presence of l-NMMA (2.08 +/- 1.34 ml/min/g vs. 1.48 +/- 1.32 ml/min/g, placebo vs. l-NMMA, p < 0.05).”
Journal of the American College of Cardiology • 2002 | View Paper
“The addition of the NO synthase competitive inhibitor, NG-monomethyl-L-arginine (NMMA), or the adenosine receptor antagonist, theophylline, prevented the increase in NO production by adenosine.”
The American journal of physiology • 1995 | View Paper
“Furthermore, infusion of NG-monomethyl-L-arginine (L-NMMA) blunted vasodilator responses to Ado infusion only in Ado responders (P < 0.01 vs. post-L-NMMA) and had no effect on exercise in either group.”
“… adenosine flow … (L-NMMA ) requires inhibition of CNS neuronal nitric oxide synthase (nNOS), increased cardiac sympathetic nerve stimulation, and β2-agonism of coronary arterioles because (1) heart … raise arterial pressure to levels equivalent to those given L-NMMA plus adenosine also did not show increased myocardial blood flow (MBF).”
“RBF during combined infusion of L-NMMA and adenosine was not different from that during adenosine alone, but the decrease in renal vascular resistance was less pronounced during this combination.”
Journal of the American College of Cardiology • 1996 | View Paper
“Before infusion of L-NMMA, adenosine caused a dose-dependent increase in FBF from 2.3 to 15.9 mL.min-1.dL-1.”
“During concurrent infusion of L-NMMA, adenosine increased FBF from 1.7 to 10.0 mL.min-1.dL-1, and this change from baseline was significantly reduced compared with that before L-NMMA (P < .05).”
“ L-NMMA also attenuated the FBF response to adenosine when the basal constrictor effect of L-NMMA was prevented by coinfusion of the NO donor sodium nitroprusside (n = 6, P < .01).”
“ Adenosine applied via pressurized micropipettes directly onto the wall or at a distance of 25 µm from the wall of first-order … diameter = 54 ± 1 µm) elicited dose-dependent dilations of 15–46% that were significantly reduced by the NO synthase inhibitor NG-monomethyl-L-arginine (L-NMMA, …–4M).”